{"id":179667,"date":"2026-02-05T08:25:56","date_gmt":"2026-02-05T13:25:56","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=179667"},"modified":"2026-02-05T08:25:56","modified_gmt":"2026-02-05T13:25:56","slug":"metropolis-healthcare-reports-26-revenue-growth-in-q3-board-approves-31-bonus-issue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-reports-26-revenue-growth-in-q3-board-approves-31-bonus-issue\/","title":{"rendered":"Metropolis Healthcare Reports 26% Revenue Growth in Q3; Board Approves 3:1 Bonus Issue"},"content":{"rendered":"\n<p><em>India\u2019s second-largest diagnostic chain saw net profit surge 63% on an adjusted basis as specialty testing and acquisition integrations drove volume growth. The company is continuing its &#8220;Metropolis 3.0&#8221; strategy to expand its footprint in Tier II and Tier III markets.<\/em><\/p>\n\n\n\n<p>Metropolis Healthcare Limited (NSE: METROPOLIS) reported a 26% year-on-year increase in consolidated revenue to \u20b9406 crore for the third quarter ended December 31, 2025. Adjusted profit after tax (PAT), excluding an exceptional item related to the new labor code, rose 63% to \u20b951 crore. This performance was supported by a 14% increase in patient volumes and a 13% rise in test volumes, reflecting sustained demand for organized diagnostic services.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Strategic Expansion Drives Diagnostic Growth<\/strong><\/h2>\n\n\n\n<p>The company\u2019s board of directors approved a bonus issue of equity shares in a 3:1 ratio. Operationally, growth was driven by the successful integration of recent acquisitions, including Core Diagnostics, Scientific Pathology (Agra), and Dr. Ahuja\u2019s Pathology &amp; Imaging Center (Dehradun). These acquisitions contributed to a favorable shift in the test mix toward specialized and complex diagnostics. The company also expanded its service network to approximately 750 towns, up from 300 in fiscal year 2023.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Metropolis Achieves Double-Digit Growth<\/strong><\/h2>\n\n\n\n<p>Metropolis reported an EBITDA of \u20b995 crore for the quarter, representing a 32.4% increase over the same period last year. The group EBITDA margin reached 23.4%, an improvement of 120 basis points year-on-year 6, 8. Revenue per patient (RPP) grew by 10% to \u20b91,165, while revenue per test (RPT) increased by 11% to \u20b9557. Business-to-consumer (B2C) revenue grew 19% to \u20b9232 crore, while business-to-business (B2B) revenue increased 35% to \u20b9174 crore. For the first nine months of the fiscal year, revenue totaled \u20b91,221 crore, a 24% increase compared to the previous year.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Metropolis 3.0 Strategic Growth Plan<\/strong><\/h2>\n\n\n\n<p>Management&#8217;s &#8220;Metropolis 3.0&#8221; strategy focuses on expanding market share in core and new geographies through a micro-market approach. The company is prioritizing specialized testing and wellness segments, with its TruHealth and Specialty portfolios recording growth of 37% and 34% respectively in the third quarter. Recent initiatives include the launch of a Centre of Genomics in partnership with Illumina to scale advanced next-generation sequencing (NGS). The company aims for a mid-teen revenue CAGR from FY23 to FY26 and intends to achieve pre-pandemic margin profiles through increased productivity and digital transformation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Transformation of India\u2019s Diagnostic Landscape<\/strong><\/h2>\n\n\n\n<p>The Indian diagnostic sector is undergoing an inflection point characterized by a shift toward organized national chains and rising adoption of preventive healthcare. Growth in the industry is increasingly coming from Tier II and Tier III cities, where Metropolis reported a 16% revenue increase during the quarter. The macro environment is further shaped by an increasing chronic disease burden and higher demand for precision diagnostics, which the company is addressing through investments in artificial intelligence and molecular genomics.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"936\" height=\"510\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-1.gif\" alt=\"\" class=\"wp-image-179668\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>India\u2019s second-largest diagnostic chain saw net profit surge 63% on an adjusted basis as specialty testing and acquisition integrations drove volume growth. The company is continuing its &#8220;Metropolis 3.0&#8221; strategy to expand its footprint in Tier II and Tier III markets. Metropolis Healthcare Limited (NSE: METROPOLIS) reported a 26% year-on-year increase in consolidated revenue to [&hellip;]<\/p>\n","protected":false},"author":2380,"featured_media":125269,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,1941,5747,5],"tags":[8157,15568],"class_list":["post-179667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-stock-analysis","category-healthcare-stocks","category-latest","tag-healthcare","tag-healthcare-sector-india"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":179566,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-posts-higher-revenue-and-margins-in-q3-fy26-on-volume-growth-and-mix-improvement\/","url_meta":{"origin":179667,"position":0},"title":"Metropolis Healthcare posts higher revenue and margins in Q3 FY26 on volume growth and mix improvement","author":"Staff Correspondent","date":"February 4, 2026","format":false,"excerpt":"Metropolis Healthcare Limited (BSE: 542650 \/ NSE: METROPOLIS) reported higher revenue and profitability in the quarter ended December 31, 2025, supported by rising patient and test volumes, stronger B2C and B2B traction, and an improved mix toward specialty and TruHealth offerings. For Q3 FY26 (MHL Group), revenue increased 26% year-on-year\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":170978,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-q1-fy26-earnings-results\/","url_meta":{"origin":179667,"position":1},"title":"Metropolis Healthcare Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"September 5, 2025","format":false,"excerpt":"Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Presenting below are its Q1 FY26 earnings results. \u00a0 Q1 FY26 Earnings Results Revenue: \u20b9386 crores, up 23% YoY (Q1 FY25: \u20b9313.4\u2013315.8\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Metropolis Healthcare Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/09\/2-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142411,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-limited-q3fy23-earnings\/","url_meta":{"origin":179667,"position":2},"title":"Metropolis Healthcare Limited Q3FY23 Earnings","author":"Karan_Singh","date":"February 21, 2023","format":false,"excerpt":"Metropolis Healthcare Limited is among the leading diagnostic companies in India. The company has a great geographical presence across nations including India, the Middle East, Africa, and South Asia. Financial Results: In the third quarter of FY23, the company suffered a drop of 12.77 percent YoY in net profits from\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":156570,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-ltd-q2fy24-10-fall-in-profits\/","url_meta":{"origin":179667,"position":3},"title":"Metropolis Healthcare Ltd Q2FY24; 10% fall in Profits","author":"Hardik Bhandare","date":"November 22, 2023","format":false,"excerpt":"Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Financial Results: Metropolis Healthcare Ltd reported Revenues for Q2FY24 of \u20b9308.00 Crores up from \u20b9300.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-293.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":148094,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-q4fy23-earnings-story\/","url_meta":{"origin":179667,"position":4},"title":"Metropolis Healthcare Q4FY23 Earnings Story","author":"Karan_Singh","date":"June 2, 2023","format":false,"excerpt":"Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Financial Results: Metropolis Healthcare Ltd. reported Total Income for Q4FY23 of \u20b9 282.5 Crores up from \u20b9 305.9 Crore year on year,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":166983,"url":"https:\/\/alphastreet.com\/india\/metropolis-healthcare-ltd-q3fy25-15-rise-in-profits\/","url_meta":{"origin":179667,"position":5},"title":"Metropolis Healthcare Ltd Q3FY25; 15% rise in Profits","author":"Chirag Gupta","date":"February 19, 2025","format":false,"excerpt":"Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Financial Results: Metropolis Healthcare Ltd reported Revenues for Q3FY25 of \u20b9323.00 Crores up from \u20b9291.00 Crore year on year, a rise of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-12.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2380"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179667"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179667\/revisions"}],"predecessor-version":[{"id":179669,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179667\/revisions\/179669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125269"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}